Trial studying safety and effects for Fatigue Syndrome, Chronic
Official title Effectiveness of Acceptance Commitment Therapy or Micro Breaks in Patients with Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis
ClinicalTrials.gov ID: NCT05168124
What this study is testing
- What it's testing
- The study wants to find out how two non‑drug therapies, Acceptance Commitment Therapy and Micro Breaks, affect symptoms and daily functioning in people with CFS/ME.
- Who it's for
- Adults who have chronic fatigue syndrome/myalgic encephalomyelitis diagnosed by the standard IOM criteria.
- What's involved
- Participants join a group program that teaches either Acceptance Commitment Therapy or Micro Breaks, give saliva and blood samples, wear a small activity monitor, and complete questionnaires about their health.
- Time commitment
- The study involves regular therapy sessions and clinic visits over several months, with sample collection and questionnaires at scheduled times.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Diagnosis for CFS/ME
- No diagnostic change to other categories of the International Classification of Diseases (ICD-10)
- No psychiatric inpatient treatments
- No psychiatric emergency treatments
- No suicide attempts
You likely can't join if
- Insufficient knowledge of German
- Severe psychiatric disorders (e.g. personality and posttraumatic stress disorders, dissociative and psychotic disorders, intelligence reduction...
- Untreated or severe internal medicine disorders e.g., thyroid dysfunction, central and obstructive sleep apnea syndrome (i.e., apnea-hypopnea index...
- Cardiovascular disease such as chronic heart failure
- Severe or untreated neurological diseases (e.g. Parkinson's disease, dementia, restless legs syndrome, narcolepsy)
- Alcohol and drug dependence
See the full eligibility criteria
- Diagnosis for CFS/ME
- No diagnostic change to other categories of the International Classification of Diseases (ICD-10)
- No psychiatric inpatient treatments
- No psychiatric emergency treatments
- No suicide attempts
- Possession of internet access
- Sufficient skills to use electronic devices
- The willingness to engage in the described therapeutic procedures or interventions (ACT, MBEL)
- Insufficient knowledge of German
- Severe psychiatric disorders (e.g. personality and posttraumatic stress disorders, dissociative and psychotic disorders, intelligence reduction, untreated attention deficit hyperactivity disorder) and acute suicidal...
- Untreated or severe internal medicine disorders e.g., thyroid dysfunction, central and obstructive sleep apnea syndrome (i.e., apnea-hypopnea index \>15 and/or "high-risk group for obstructive sleep apnea" according to...
- Cardiovascular disease such as chronic heart failure
- Severe or untreated neurological diseases (e.g. Parkinson's disease, dementia, restless legs syndrome, narcolepsy)
- Alcohol and drug dependence
- Initiation of psychopharmacotherapy at a dosage provided for guideline-appropriate treatment of a mental disorder according to the Drug Compendium in the past 3 months
- Start of other psychotherapy procedures in the last 3 months
- Other parallel therapy methods (e.g. acupuncture, qigong, osteopathy)
- Somatic (sleep-disrupting) treatments, cortisone treatment, or radio-/chemotherapy in the last 6 months
The study team makes the final eligibility decision.
Where it is enrolling
- Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Zurich, Switzerland. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.